SCHEMBL16973788

SCHEMBL16973788

COc1ccc(CC(C(N)=O)C2CC2)cc1OC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LDHA P00338 1/20 0.57
▸ CA2 P00918 4/20 0.50
▸ CA1 P00915 3/20 0.50
▸ CA9 Q16790 3/20 0.50
▸ CA12 O43570 2/20 0.50
▸ STAT3 P40763 1/20 0.49
▸ KDM4E B2RXH2 1/20 0.47
▸ ATM Q13315 1/20 0.47
▸ ALOX15 P16050 2/20 0.47
▸ ALOX12 P18054 1/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ MEN1 O00255 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ EPHX1 P07099 1/20 0.46
▸ PKM P14618 1/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ SIGMAR1 Q99720 1/20 0.46
▸ CYP19A1 P11511 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20059229 0.80 LDHA (0.54) LDHACA2CA1CA9CA12
SCHEMBL16930062 0.79 LDHA (0.51) LDHACA2CA1CA9CA12
SCHEMBL9356853 0.77 LDHA (0.66) LDHACA2STAT3KDM4EATM
SCHEMBL4998033 0.76 LDHA (0.64) LDHACA2CA1CA9CA12
Hydrochloric Acid SCHEMBL9352848 0.76 LDHA (0.64) LDHACA2STAT3KDM4EATM
SCHEMBL16973420 0.75 LDHA (0.62) LDHACA2KDM4EATMALOX15
SCHEMBL9444655 0.74 LDHA (0.66) LDHACA2STAT3KDM4EATM
SCHEMBL9352795 0.74 LDHA (0.60) LDHACA2CA1CA9CA12
SCHEMBL490731 0.73 LDHA (1.00) LDHACA2CA1CA9CA12
SCHEMBL159001 0.73 LDHA (0.73) LDHAKDM4EALOX15ALOX12ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3099685-A1 NOVEL DIHYDROQUINOLIZINONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2016-12-07 — — EP disclosed
WO-2015113990-A1 NOVEL DIHYDROQUINOLIZINONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2015-08-06 — — WO disclosed
Send feedback